Lion Point Capital, LP Hedge Fund

CIK: 0001643354 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $14,729 (100.0% shares, 0.0% debt)

Holdings (19)

FENC FENNEC PHARMACEUTICALS INC 11.0%
Value ($000) $1,624 Shares 195,700 Est. Cost $8.27 Unrealized -17.3%
ARDX ARDELYX INC 8.9%
Value ($000) $1,315 Shares 335,400 Est. Cost $1.61 Unrealized +155.8%
KNSA KINIKSA PHARMACEUTICALS INTL 8.6%
Value ($000) $1,270 Shares 45,900 Est. Cost $18.73 Unrealized +35.9%
BBIO BRIDGEBIO PHARMA INC 7.6%
Value ($000) $1,123 Shares 26,000 Est. Cost $27.34 Unrealized +33.0%
INSM INSMED INC 7.3%
Value ($000) $1,072 Shares 10,650 Est. Cost $21.50 Unrealized +255.7%
MLYS MINERALYS THERAPEUTICS INC 7.3%
Value ($000) $1,069 Shares 79,000 Est. Cost $12.41 Unrealized +16.8%
MIST MILESTONE PHARMACEUTICALS IN 7.2%
Value ($000) $1,065 Shares 548,806 Est. Cost $3.14 Unrealized -57.5%
AVADEL PHARMACEUTICALS PLC 5.9%
Value ($000) $873 Shares 98,700 Est. Cost $11.87 Unrealized
JSPR JASPER THERAPEUTICS INC 5.5%
Value ($000) $813 Shares 146,500 Est. Cost $9.08 Unrealized -45.8%
BNTC BENITEC BIOPHARMA INC 4.9%
Value ($000) $725 Shares 62,000 Est. Cost $9.63 Unrealized +45.2%
GERN GERON CORP 4.8%
Value ($000) $705 Shares 500,000 Est. Cost $2.31 Unrealized -38.7%
ARQT ARCUTIS BIOTHERAPEUTICS INC 4.4%
Value ($000) $649 Shares 46,300 Est. Cost $10.13 Unrealized +38.4%
IRON DISC MEDICINE INC 3.8%
Value ($000) $561 Shares 10,600 Est. Cost $49.93 Unrealized -5.9%
SNDX SYNDAX PHARMACEUTICALS INC 3.5%
Value ($000) $515 Shares 55,000 Est. Cost $20.81 Unrealized -47.1%
RGNX REGENXBIO INC 3.2%
Value ($000) $474 Shares 57,750 Est. Cost $15.56 Unrealized -46.2%
BHVN BIOHAVEN LTD 2.2%
Value ($000) $320 Shares 22,700 Est. Cost $38.91 Unrealized -54.2%
MERSANA THERAPEUTICS INC 1.3%
Value ($000) $191 Shares 644,000 Est. Cost $0.34 Unrealized
MCRB SERES THERAPEUTICS INC 1.3%
Value ($000) $189 Shares 17,038 Est. Cost $8.80 Unrealized 0.0%
HUMA HUMACYTE INC 1.2%
Value ($000) $175 Shares 83,500 Est. Cost $3.75 Unrealized -48.8%